<DOC>
	<DOCNO>NCT03106116</DOCNO>
	<brief_summary>The purpose study investigate efficacy Enhanced External Counterpulsation ( EECP ) therapy ventricular function patient coronary heart disease</brief_summary>
	<brief_title>Efficacy Enhanced External Counterpulsation Ventricular Function</brief_title>
	<detailed_description>Patients coronary heart disease randomize two group : standard medical treatment standard medical treatment plus EECP intervention . Ventricular structure function measure compare .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>More 50 % stenosis leave main trunk 3 epicardial coronary artery large branch show coronary angiography Or history myocardial infarction Or history prior revascularization Signed informed consent participate study Clinically significant valvular heart disease Aortic aneurysm Congenital heart disease Acute myocarditis Arrhythmias significantly interfere trigger EECP device History cerebral hemorrhage Hemorrhagic disease Lower limb infection , phlebitis Deep venous thrombosis Malignant disease International normalize ratio ( INR ) &gt; 2.5 Uncontrolled hypertension , define systolic blood pressure &gt; 180mmHg diastolic blood pressure &gt; 110mmHg Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Ventricular Function</keyword>
	<keyword>Vascular Endothelium</keyword>
	<keyword>Counterpulsation , External</keyword>
</DOC>